Utah Chapter Webcast: ISO 13485 and the FDA QMSR

RAC Credits
Chapter Events Chapter Events
Tuesday, 09 August 2022 (1:00 PM) - Tuesday, 09 August 2022 (2:00 PM) Central Time (US & Canada)

This session is designed to inform the attendees about the FDA’s proposed rule to amend the device current good manufacturing practice (CGMP) requirements of the Quality System (QS) Regulation to align more closely with the international consensus standard for Quality Management Systems for medical devices used by many other regulatory authorities around the world.

The FDA proposes to do so primarily by incorporating by reference the 2016 edition of the international standard specific for medical device quality management systems set by the International Organization for Standardization (ISO), ISO 13485. Through this rulemaking, the FDA is also proposing additional requirements that help connect and align ISO 13485 with existing requirements in the Federal Food, Drug, and Cosmetic Act and its implementing regulations, and make conforming edits to 21 CFR Part 4 to clarify the device CGMP requirements for combination products.

Who Should Attend?

Oriented primarily towards medical device professionals, those engaged in the following functions will derive great benefit from attending.

  • Regulatory professionals
  • Supply chain
  • Design and Manufacturing
  • Quality


For the best webcast experience, please use the Google Chrome browser. RAPS webcasts are also mobile- and tablet-accessible for your convenience. Registrants will receive instructions on how to log in 24 hours before the start of the webcast. A live Q&A portion with the speaker will follow the presentation.


RAPS membership provides vital information for regulatory professionals and a place for networking and invaluable connections. Now is a great time to explore the many benefits of RAPS membership, including the Member Knowledge Center and our award-winning, private online community, Regulatory Exchange. Find out more about RAPS membership today.


Kimberly Trautman

Kimberly Trautman
MD and Vice President, MEDIcept Inc.

Kim is an expert in Medical Device, InVitro Diagnostics, and Combination Products. She brings over 30 years of experience in the field, spanning her work at the US FDA for over 24 years, as well as working with Regulatory Agencies around the globe. With a demonstrated history of working collaboratively with industry, regulators, and patient groups for the betterment of public health her perspectives are comprehensive and pragmatic at the same time.

She has also been engaged in (a) writing and harmonizing the current 1996 US FDA Quality System Regulation and was on the international authoring group of ISO 13485 since inception in 1994, and, a twenty year veteran of the Global Harmonization Tasks Force (GHTF) and foundational member of the International Medical Device Regulators Forum (IMDRF).

Kim earned her Master's Degree in Biomedical Engineering from University of Virginia, and has won awards as FDA Engineer of the Year, and for Distinguished Service from the US Department of Health and Human Services.

Cancellation Policy

RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation.

All cancellation requests must be submitted in writing to raps@raps.org. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.

Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email raps@raps.org with the event title, name of the original registrant and the contact information for the new attendee.

Proof of Attendance

RAPS will send an electronic letter or a certificate of attendance at the following the webcast.


Contact the RAPS Support Center:

Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email support@raps.org

Discover more of what matters to you

News »